Literature DB >> 22371647

Amplifications of NCOA3 gene in colorectal cancers in a Chinese population.

Zhi Li1, Zheng-Yu Fang, Yi Ding, Wan-Tong Yao, Yang Yang, Zhong-Qing Zhu, Wen Wang, Qin-Xian Zhang.   

Abstract

AIM: To investigate the copy number variation of NACO3 gene in colorectal cancer (CRC) and its correlation with tumor progression.
METHODS: A total of 142 samples of case-matched CRC tissues and adjacent normal tissues were obtained from patients undergoing bowel resection. Quantitative real-time polymerase chain reaction method was used to investigate the copy number variations of NCOA3 as well as gene expression in the collected tissues.
RESULTS: Copy number gains of NCOA3 were detected in 39 CRC samples (27.5%) and were correlated with tumor progression (χ2 = 6.42, P = 0.0112). Moreover, there was a positive correlation between copy number gain and mRNA over-expression of NCOA3 in CRCs (P = 0.0023). Expression level of NCOA3 mRNA was also enhanced in the CRC samples with unaltered copy numbers (3.85 ± 1.23 vs. 2.71 ± 0.64, P < 0.01).
CONCLUSION: Sporadic colorectal cancers exhibit different mechanisms of NCOA3 regulation.

Entities:  

Keywords:  Colorectal cancer; Gene copy number; Gene expression; NCOA3; Tumor progression

Mesh:

Substances:

Year:  2012        PMID: 22371647      PMCID: PMC3286150          DOI: 10.3748/wjg.v18.i8.855

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Side effects of genome structural changes.

Authors:  Alexandre Reymond; Charlotte N Henrichsen; Louise Harewood; Giuseppe Merla
Journal:  Curr Opin Genet Dev       Date:  2007-10-24       Impact factor: 5.578

3.  Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.

Authors:  Rebeqa Gunnarsson; Johan Staaf; Mattias Jansson; Anne Marie Ottesen; Hanna Göransson; Ulrika Liljedahl; Ulrik Ralfkiaer; Mahmoud Mansouri; Anne Mette Buhl; Karin Ekström Smedby; Henrik Hjalgrim; Ann-Christine Syvänen; Ake Borg; Anders Isaksson; Jesper Jurlander; Gunnar Juliusson; Richard Rosenquist
Journal:  Genes Chromosomes Cancer       Date:  2008-08       Impact factor: 5.006

4.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

5.  Global variation in copy number in the human genome.

Authors:  Richard Redon; Shumpei Ishikawa; Karen R Fitch; Lars Feuk; George H Perry; T Daniel Andrews; Heike Fiegler; Michael H Shapero; Andrew R Carson; Wenwei Chen; Eun Kyung Cho; Stephanie Dallaire; Jennifer L Freeman; Juan R González; Mònica Gratacòs; Jing Huang; Dimitrios Kalaitzopoulos; Daisuke Komura; Jeffrey R MacDonald; Christian R Marshall; Rui Mei; Lyndal Montgomery; Kunihiro Nishimura; Kohji Okamura; Fan Shen; Martin J Somerville; Joelle Tchinda; Armand Valsesia; Cara Woodwark; Fengtang Yang; Junjun Zhang; Tatiana Zerjal; Jane Zhang; Lluis Armengol; Donald F Conrad; Xavier Estivill; Chris Tyler-Smith; Nigel P Carter; Hiroyuki Aburatani; Charles Lee; Keith W Jones; Stephen W Scherer; Matthew E Hurles
Journal:  Nature       Date:  2006-11-23       Impact factor: 49.962

6.  Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.

Authors:  Adam Shlien; Uri Tabori; Christian R Marshall; Malgorzata Pienkowska; Lars Feuk; Ana Novokmet; Sonia Nanda; Harriet Druker; Stephen W Scherer; David Malkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

7.  Distribution and functional impact of DNA copy number variation in the rat.

Authors:  Victor Guryev; Kathrin Saar; Tatjana Adamovic; Mark Verheul; Sebastiaan A A C van Heesch; Stuart Cook; Michal Pravenec; Timothy Aitman; Howard Jacob; James D Shull; Norbert Hubner; Edwin Cuppen
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

8.  Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA).

Authors:  Vladimir Grubor; Alex Krasnitz; Jennifer E Troge; Jennifer L Meth; B Lakshmi; Jude T Kendall; Boris Yamrom; Garrick Alex; Deepa Pai; Nicholas Navin; Lisa A Hufnagel; Yoon-Ha Lee; Kerry Cook; Steven L Allen; Kanti R Rai; Rajendra N Damle; Carlo Calissano; Nicholas Chiorazzi; Michael Wigler; Diane Esposito
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

9.  A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.

Authors:  Sarina Sulong; Anthony V Moorman; Julie A E Irving; Jonathan C Strefford; Zoe J Konn; Marian C Case; Lynne Minto; Kerry E Barber; Helen Parker; Sarah L Wright; Adam R M Stewart; Simon Bailey; Nick P Bown; Andrew G Hall; Christine J Harrison
Journal:  Blood       Date:  2008-10-06       Impact factor: 22.113

10.  Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.

Authors:  Dariush Etemadmoghadam; Anna deFazio; Rameen Beroukhim; Craig Mermel; Joshy George; Gad Getz; Richard Tothill; Aikou Okamoto; Maria B Raeder; Paul Harnett; Stephen Lade; Lars A Akslen; Anna V Tinker; Bianca Locandro; Kathryn Alsop; Yoke-Eng Chiew; Nadia Traficante; Sian Fereday; Daryl Johnson; Stephen Fox; William Sellers; Mitsuyoshi Urashima; Helga B Salvesen; Matthew Meyerson; David Bowtell
Journal:  Clin Cancer Res       Date:  2009-02-03       Impact factor: 12.531

View more
  3 in total

1.  NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.

Authors:  S Kumar; S Das; S Rachagani; S Kaur; S Joshi; S L Johansson; M P Ponnusamy; M Jain; S K Batra
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

2.  Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.

Authors:  Rupal Sinha; Showket Hussain; Ravi Mehrotra; R Suresh Kumar; Kapil Kumar; Pankaj Pande; Dinesh Chandra Doval; Seemi Farhat Basir; Mausumi Bharadwaj
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

3.  RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition.

Authors:  María Fernanda Rubio; María Cecilia Lira; Francisco Damián Rosa; Adrían Dario Sambresqui; María Cecilia Salazar Güemes; Mónica Alejandra Costas
Journal:  Cancer Cell Int       Date:  2017-11-28       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.